Skip to main content
TipRanks
Go Ultimate75% OFF

Eurofins-Cerep SA (ALECR) AI Stock Analysis

0 Followers
FR:ALECR

Eurofins-Cerep SA

(Paris:ALECR)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Negative Factors

Eurofins-Cerep SA (ALECR) vs. iShares MSCI France ETF (EWQ)

-10%-5%0%5%10%15%20%FR:ALECR-6.83%EWQ+1.77%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 75.67M
Dividend Yield
―
Average Volume (3M)
1
Price to Earnings (P/E)
17.0
Beta (1Y)
-0.06
Revenue Growth
1.28%
EPS Growth
-33.15%
Country
France
Employees
209
Sector
General
Sector Strength
55
Industry
Medical - Diagnostics & Research

Eurofins-Cerep SA Business Overview & Revenue Model

Company Description

Established in 1989 and headquartered in Vienne, France, Eurofins Cerep SA delivers a broad spectrum of drug discovery support to pharmaceutical and biotechnology enterprises across the globe. The company's specialized offerings include the managemen...

Eurofins-Cerep SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

FR:ALECR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:BIMFR:BIM73OutperformEUR 10.70B23.0711.01%1.08%-3.18%22.52%
FR:ALERSFR:ALERS58NeutralEUR 259.38M37.713.89%―6.28%204.56%
FR:ERFFR:ERF57NeutralEUR 15.04B28.4914.81%0.84%3.38%28.21%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
FR:ALNOVFR:ALNOV45NeutralEUR 31.50M-0.75-159.70%―10.36%29.41%

* General Sector Average

Performance Comparison

0%50%100%FR:ALECRFR:BIMFR:ERFFR:ALNOVFR:ALERSFR:ABLDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:ALECR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:ALECREurofins-Cerep SA15000.00-1100.00-6.83%
FR:BIMbioMerieux SA90.65-13.81-13.22%
FR:ERFEurofins Scientific85.4628.7350.65%
FR:ALNOVNovacyt S.A.0.430.000.93%
FR:ALERSEurobio-Scientific SA26.402.008.20%
FR:ABLDABL Diagnostics SA2.40-0.23-8.57%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.